Life sciences companies are leveraging digitalization, new and evolving technologies, and third-party providers to boost innovation, quality, and speed.
These compelling advances also introduce cybersecurity vulnerabilities. Recent failures within companies and their third-party providers have led to significant and mounting harms. As an essential constituent of technology and business strategy, threats and risks must be evaluated and managed.
Understanding current and emerging cybersecurity threats and risks and how to deal with them is critical to the protection of intellectual properties, data, and patient privacy, and to continuous regulatory compliance.
Here is a sampling of what Roger and Dom shared in this webinar. Click Watch Now for the full-length webinar.
Click Watch Now for the full-length webinar.
About the Presenters
Director of Customer Engagement Roger has more than 20 years of experience in both consulting and industry roles in the pharma, biotech, engineering, and semiconductor industries. Working with small and large life sciences firms, Roger has built and led professional services teams to deliver solutions for customer needs and challenges.
Chief Security Officer and Chief Security Strategist, CyberSN Mr. Glavach has more than 20 years of cybersecurity experience in commercial industries and as a contractor for the Department of Defense and intelligence communities. In this executive role, he is responsible for leading the company’s information security strategy, policy, IT operations, security engineering, security operations, data privacy, and cyber threat detection.